Skip to main content
Clinical Trials/NCT01815931
NCT01815931CompletedNot Applicable

Hemolysis in Blood Samples in the ER

University Hospital, Geneva1 site in 1 country2,800 target enrollmentStarted: June 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
2,800
Locations
1
Primary Endpoint
Hemolysis rate

Study Overview

Brief Summary

In this study, we aim to identify risk factors for hemolysis in blood samples drawn in the ED.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • > 16 years

Exclusion Criteria

  • In vivo hemolysis

Outcomes

Primary Outcomes

Hemolysis rate

Time Frame: 1 day

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Olivier T. Rutschmann

MD, MPH

University Hospital, Geneva

Study Sites (1)

Loading locations...

Similar Trials

Hemolysis in Blood Samples in the ER | Clinical Trial